• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身 MRI 和动态对比增强 MRI 在多发性骨髓瘤的诊断、随访及疾病活动度和范围评估中的价值。

Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.

机构信息

Department of Radiology, MR-1K12, Ghent University, De Pintelaan 185, B-9000 Ghent, Belgium.

出版信息

Eur J Radiol. 2013 Sep;82(9):1444-52. doi: 10.1016/j.ejrad.2013.04.012. Epub 2013 May 28.

DOI:10.1016/j.ejrad.2013.04.012
PMID:23726124
Abstract

PURPOSE

To evaluate the significance of dynamic contrast enhanced MRI (DCE-MRI) and whole body MRI (WB-MRI) in the diagnosis, prognosis and assessment of therapy for patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM).

MATERIALS AND METHODS

The retrospective study includes 219 patients providing 463 WB-MRI and DCE-MRI investigations for the subgroups MGUS (n=70), MM active disease (n=126; this includes 70 patients with new diagnosis of MM, according to the International Staging System (ISS): 41.4% ISS stage I, 20.0% ISS stage II, 7.1% ISS stage III, 31.4% insufficient for staging; and 56 patients with '(re-)active disease': 16.07% relapse, 32.14% progressive disease and 51.79% stable disease) and MM remission (n=23; 60.87% complete remission, 17.39% very good partial remission and 21.74% partial remission). Investigations of patients with hereditary multiple exostoses (n=5), neurofibromatosis (n=7) and healthy persons (n=9) were added as control subjects (n=21). WB-MRI evaluation was done by evaluating thirteen skeletal regions, providing a 'skeletal score'. DCE-MRI images of the spine, were analyzed with regions-of-interest and time-intensity-curves (TIC).

RESULTS

All TIC parameters can significantly differentiate between the predefined subgroups (p<0.001). One hundred days after autologous stem cell transplantation a 75% decrease of the slope wash-in value (p<0.001) can be seen. A cubic regression trend between 'skeletal score' and slope wash-in (adj.R(2)=0.412) could demonstrate a significant increase bone marrow perfusion if MM affects more than 10 skeletal regions (p<0.001), associated with a poorer prognosis (p<0.001).

CONCLUSION

DCE-MRI evaluation of the spine is useful for diagnosis of MM, follow-up after stem cell transplantation and evaluation of disease activity. A combined evaluation with WB-MRI and DCE-MRI provides additional micro-vascular information on the morphologic lesions and could help categorize patients with MM in two different groups to offer useful therapeutic and prognostic advise.

摘要

目的

评估动态对比增强磁共振成像(DCE-MRI)和全身磁共振成像(WB-MRI)在单克隆丙种球蛋白病(MGUS)和多发性骨髓瘤(MM)患者的诊断、预后和疗效评估中的意义。

材料与方法

本回顾性研究纳入 219 例患者,共进行了 463 次 WB-MRI 和 DCE-MRI 检查,分为 MGUS 亚组(n=70)、MM 活动期疾病(n=126;包括新诊断的 MM 患者 70 例,根据国际分期系统(ISS):ISS 分期 I 期 41.4%、ISS 分期 II 期 20.0%、ISS 分期 III 期 7.1%、ISS 分期不足 31.4%;以及 56 例“(再)活动性疾病”:复发 16.07%、进展性疾病 32.14%、稳定疾病 51.79%)和 MM 缓解期(n=23;完全缓解 60.87%、非常好的部分缓解 17.39%、部分缓解 21.74%)。还纳入遗传性多发性外生骨疣(n=5)、神经纤维瘤病(n=7)和健康人(n=9)作为对照(n=21)。对 13 个骨骼区域进行 WB-MRI 评估,提供“骨骼评分”。对脊柱 DCE-MRI 图像进行感兴趣区和时间-强度曲线(TIC)分析。

结果

所有 TIC 参数均能在预设的亚组间进行显著区分(p<0.001)。自体干细胞移植后 100 天,斜率达峰时间值的下降幅度为 75%(p<0.001)。脊柱 DCE-MRI 的斜率达峰时间值与“骨骼评分”之间存在立方回归趋势(adj.R²=0.412),如果 MM 累及 10 个以上骨骼区域,骨髓灌注明显增加(p<0.001),且预后较差(p<0.001)。

结论

脊柱 DCE-MRI 评估对 MM 的诊断、干细胞移植后的随访和疾病活动度的评估均有帮助。WB-MRI 和 DCE-MRI 的联合评估可提供形态学病变的额外微血管信息,并可将 MM 患者分为两个不同的组,为提供有价值的治疗和预后建议提供帮助。

相似文献

1
Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.全身 MRI 和动态对比增强 MRI 在多发性骨髓瘤的诊断、随访及疾病活动度和范围评估中的价值。
Eur J Radiol. 2013 Sep;82(9):1444-52. doi: 10.1016/j.ejrad.2013.04.012. Epub 2013 May 28.
2
Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.单克隆浆细胞疾病在全身磁共振成像中的表现及其与疾病活动参数的相关性。
Int J Cancer. 2014 Nov 15;135(10):2380-6. doi: 10.1002/ijc.28877. Epub 2014 Apr 17.
3
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation.动态对比增强磁共振成像可识别出一组患有无症状单克隆浆细胞病和病理性微循环的患者。
Clin Cancer Res. 2009 May 1;15(9):3118-25. doi: 10.1158/1078-0432.CCR-08-2310. Epub 2009 Apr 14.
4
Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.动态对比增强磁共振成像测量的腰椎骨髓微循环是进展性多发性骨髓瘤无事件生存期的一个预测指标。
Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):475-81. doi: 10.1158/1078-0432.CCR-06-0061.
5
DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach.DCE-MRI 用于区分所有单克隆浆细胞疾病阶段,并与基于扩散加权 MRI/PET 的生物标志物在混合式同步全身 2-[18F]FDG-PET/MRI 成像方法中的相关性。
Cancer Imaging. 2024 Jul 11;24(1):93. doi: 10.1186/s40644-024-00740-5.
6
[MR-Imaging of lower leg muscle perfusion].[小腿肌肉灌注的磁共振成像]
Herz. 2004 Feb;29(1):32-46. doi: 10.1007/s00059-004-2532-1.
7
Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.多发性骨髓瘤和意义未明的单克隆丙种球蛋白病:全身磁共振成像与脊柱磁共振成像的重要性
Radiology. 2009 Aug;252(2):477-85. doi: 10.1148/radiol.2522081756.
8
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma.动态对比增强磁共振成像检测到的微循环增加对无症状骨髓瘤具有预后意义。
Br J Haematol. 2016 Jul;174(1):127-35. doi: 10.1111/bjh.14038. Epub 2016 Mar 15.
9
Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma.传统MRI、动态对比增强MRI和扩散加权成像联合评估用于多发性骨髓瘤患者的疗效评估
Eur J Radiol. 2016 Feb;85(2):373-82. doi: 10.1016/j.ejrad.2015.11.040. Epub 2015 Dec 2.
10
Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).多发性骨髓瘤及其前体(意义未明的单克隆丙种球蛋白血症和冒烟型骨髓瘤)的弥散加权成像和动态对比增强 MRI 综述。
Skeletal Radiol. 2022 Jan;51(1):101-122. doi: 10.1007/s00256-021-03903-8. Epub 2021 Sep 14.

引用本文的文献

1
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma.诊断创新:用于多发性骨髓瘤诊断和随访的成像技术进展
J Bone Oncol. 2025 Feb 28;51:100669. doi: 10.1016/j.jbo.2025.100669. eCollection 2025 Apr.
2
Recent advances in imaging and artificial intelligence (AI) for quantitative assessment of multiple myeloma.用于多发性骨髓瘤定量评估的成像和人工智能(AI)的最新进展。
Am J Nucl Med Mol Imaging. 2024 Aug 25;14(4):208-229. doi: 10.62347/NLLV9295. eCollection 2024.
3
Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging.
使用传统全身MRI、脊柱动态对比增强MRI和脊柱扩散加权成像预测多发性骨髓瘤的细胞遗传学风险。
Insights Imaging. 2024 Apr 10;15(1):106. doi: 10.1186/s13244-024-01672-1.
4
Hybrid simultaneous whole-body 2-[F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results.新型多发性骨髓瘤患者的 Hybrid 同步全身 2-[F]FDG-PET/MRI 成像:初步诊断性能和临床附加价值结果。
Eur Radiol. 2023 Sep;33(9):6438-6447. doi: 10.1007/s00330-023-09593-1. Epub 2023 Apr 6.
5
X-ray and MRI Correlation of Bone Tumors Using Histopathology As Gold Standard.以组织病理学为金标准的骨肿瘤X线与磁共振成像相关性研究
Cureus. 2022 Jul 25;14(7):e27262. doi: 10.7759/cureus.27262. eCollection 2022 Jul.
6
Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).多发性骨髓瘤及其前体(意义未明的单克隆丙种球蛋白血症和冒烟型骨髓瘤)的弥散加权成像和动态对比增强 MRI 综述。
Skeletal Radiol. 2022 Jan;51(1):101-122. doi: 10.1007/s00256-021-03903-8. Epub 2021 Sep 14.
7
Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines.基于近期国际指南的多发性骨髓瘤管理中影像学作用的综合更新。
Korean J Radiol. 2021 Sep;22(9):1497-1513. doi: 10.3348/kjr.2020.0886.
8
Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT.多发性骨髓瘤治疗反应和微小残留病的影像学:WB-MRI 和 PET/CT 的现状。
Skeletal Radiol. 2022 Jan;51(1):59-80. doi: 10.1007/s00256-021-03841-5. Epub 2021 Aug 7.
9
Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging.全身磁共振成像(WBMRI)与全身计算机断层扫描(WBCT)在骨髓瘤成像和分期中的比较。
Skeletal Radiol. 2022 Jan;51(1):43-58. doi: 10.1007/s00256-021-03799-4. Epub 2021 May 24.
10
Coexisting Spine Lesions on Whole Spine T2 Sagittal MRI in Evaluating Spinal Degenerative Disease.全脊柱 T2 矢状位 MRI 评估脊柱退行性疾病中的并存脊柱病变。
J Korean Med Sci. 2021 Feb 22;36(7):e48. doi: 10.3346/jkms.2021.36.e48.